Cognetivity Neurosciences Ltd. Stock

Stocks

CGNSF

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - OTC Markets 23:50:56 29/05/2026 +04 5-day change 1st Jan Change
0.000100 USD +9,900.00% Intraday chart for Cognetivity Neurosciences Ltd. -.--% +9,900.00%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 1.2M 857K 739K 680K 638K 81.04M 1.21M 8.04M 3.14M 39.68M 3.22M 3.15M 137M P/E Ratio 2022
-2.9x
P/E Ratio 2023 -2.8x
Enterprise Value 245K 175K 151K 139K 131K 16.58M 248K 1.64M 642K 8.12M 658K 644K 28.09M EV / Sales 2022
-
EV / Sales 2023 437,922,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.23
5 years 0
Extreme 0
1.12
10 years 0
Extreme 0
1.12
Manager TitleAgeSince
Chief Executive Officer 45 01/04/2013
Compliance Officer 67 21/12/2017
Director TitleAgeSince
Director/Board Member 45 01/01/2017
Director/Board Member 67 21/12/2017
Date Insider Type Main position Quantity % Market Cap.
15/04/24Option

Founder

600,000 0.6697%
15/04/24Option

Founder

600,000 0.6697%
23/06/23Sell

Founder

1,108,160 1.3030%
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-99.96% 9.36K
+1.65%-3.03%-43.01%-19.45% 25.92B
+0.34%-0.66%-39.17%+154.09% 12.08B
-3.25%-0.27%-6.88%+51.79% 6.19B
-1.26%+14.52% - - 2.87B
+5.71%-4.78%+36.70%-44.77% 1.72B
+9.69%+4.97% - - 1.59B
0.00%-4.31%-33.27%-59.89% 813M
-2.36%-1.92%-29.85%+203.67% 803M
-1.76%-1.36%-36.05%-41.12% 724M
Average +990.97%-1.70%-18.94%+18.05% 5.27B
Weighted average by Cap. +1.55%-4.07%-34.08%+34.96%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 3.07 0.05 0.3 0.12 1.5 0.12 0.12 5.2
Net income -13.13M -9.39M -8.09M -7.45M -6.99M -888M -13.26M -88.07M -34.4M -435M -35.24M -34.5M -1.5B -7.43M -5.32M -4.58M -4.22M -3.96M -503M -7.51M -49.87M -19.48M -246M -19.96M -19.53M -852M
Net Debt -82.43K -58.97K -50.83K -46.78K -43.88K -5.57M -83.25K -553K -216K -2.73M -221K -217K -9.44M -953K -682K -588K -541K -508K -64.46M -963K -6.4M -2.5M -31.57M -2.56M -2.51M -109M
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGNSF Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!